Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and influenza and a stand-alone flu vaccine, sending the company's ...
TipRanks on MSN
Novavax price target lowered to $7 from $8 at TD CowenTD Cowen lowered the firm’s price target on Novavax (NVAX) to $7 from $8 and keeps a Hold rating on the shares. The firm updated its model ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback